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TRANSCRIPTION ANALYSIS OF TIMP-1 AND 
NM23-H1 GENES IN GLIOMA CELL INVASION
José Augusto Nasser1, Asdrúbal Falavigna2, Fernando Ferraz1, 
Gregory Duigou3, Jeffrey Bruce3
ABSTRACT - Purpose: To evaluate using transcription analysis the presence and importance of two genes:
NM23-H1 and TIMP-1 on control of tumor cell invasion in diffuse astrocytomas (WHO II) and glioblastoma
multiforme (WHO IV). Method: Northern blot analysis of NM23-H1 and TIMP-1 was performed. Eight dif-
fuse astrocytomas and 19 glioblastomas (WHO IV) were analyzed to determine if TIMP-1 and NM23-H1
were candidates to inhibition of tumor cell invasion quantitated RNA levels. The samples were collected
directly from operating room. Total cellular RNA was extracted from frozen tissue samples using guani-
dinium-isothiocyanate and cesium chloride gradients. Total RNA (10 µg per sample) from tumor tissue were
size fractionated through 1% agarose-formaldehyde gel and transferred to nylon filters and then hybridized
to 32P-labeled DNA probes and placed for autoradiography. Levels of specific RNAs were determined by
computer-assisted laser densitometry. Blot filters were sequentially hybridized to nm23 and TIMP-1 probes
in addition to GAPDH, as a control. Statistical analyses were carried out according to t-test for equality of
means. Results: NM23-H1 were detected in each sample, however it did not correlate with malignancy
and invasiveness. On the other side TIMP-1 gene expression showed a clear correlation between low expres-
sion and invasiveness. Conclusion: The data suggest that TIMP-1 is an inhibitor of high grade gliomas
invasion. NM23-H1 was present in the entire gliomas sample, but it did not vary in diffuse astrocytomas
and glioblastomas.
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Análise transcricional dos genes TIMP-1 e NM23-H1 na invasão celular em astrocitoma difuso e
glioblastoma multiforme
RESUMO - Objetivo: Comparar através da análise da expressão dos níveis de RNA, a presença e a relevân-
cia dos genes NM23-H1 e TIMP-1 no controle da invasão celular tumoral dentro do tecido cerebral normal
em: astrocitoma difuso (OMS II) e glioblastoma multiforme (OMS:IV). Método: Análise em “Northern
blot” dos genes NM23-H1 e TIMP-1. Oito astrocitomas fibrilares difusos (OMS II) e 19 glioblastomas multi-
formes foram analisados para determinar se TIMP-1 e NM23-H1 estavam relacinados à inibição da invasão
tumoral nas neoplasias do sistema nervoso central, quantificando os níveis de RNA dos respectivos genes
extraídos diretamente dos tumores. 10 µg por amostra de RNA total foram fracionados de gel de formaldeí-
do e transferidos para os filmes de hibridação. Níveis específicos de RNAs foram determinados na espec-
trofotometria. Valores das razões entre NM23-H1/GAPDH e TIMP-1/GAPDH foram submetidos à análise de
variabilidade das médias. Resultados: A análise da expressão do gene TIMP-1 mostrou supressão em
tumores gliais malignos. Conclusão: Os resultados indicam que existe relação direta entre níveis baixos
de TIMP-1 e malignidade dos gliomas. O gene NM23-H1 foi detectado em todas as amostras, mas não foi
possível relacionar sua subexpressão ou superexpressão com algum fenótipo de invasividade.
PALAVRAS-CHAVE: invasão celular tumoral, TIMP-1, NM23-H1, níveis de RNA, gliomas.
Tumor cell invasion into normal brain is a major
component of brain tumor malignancy. In contrast
to other tumors, brain tumors are often invasive, but
rarely metastasize to distant sites. An understanding
of the genes which control tumor cell invasion will
allow the development of therapeutic regimens de-
signed to counteract this complex property. Although
there are reports of genes that may modulate the
ability of a brain tumor cell to invade adjacent nor-
mal brain, the molecular control of brain tumor inva-
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siveness is still not well-defined. Specific secreted pro-
teases including heparinases plus serine-,thiol- and
metal-dependent proteinases have been implicated
in tumor cell invasion1. 
The most well-studied of these enzymes are the
metalloproteinases. Metalloproteinases are a family
of protein-degrading enzymes that digest compo-
nents of the extracellular matrix (ECM), the support-
ing material that functions to cement cells in place
within tissues. These proteins have been implicated
in wound healing, uterine, involution, embryogen-
esis, tissue remodeling, angiogenesis, parasite and
bacterial invasion, rheumatoid arthritis and tumor
cell invasion. The metalloproteinases are sub grouped
into three categories: interstitial collagenases, type
IV collagenases and stromelysins (transin). These en-
zymes are secreted as inactive proenzyme forms and
must be activated by removal of an amino terminal
fragment. Left unchecked, the activated metallopro-
teinases would destroy the structural integrity of tis-
sues. Cells have involved mechanisms to protect them-
selves and their surroundings by excreting proteins
that inactivate the metalloproteinases. Important
representatives of this group of proteins are the tis-
sue inhibitors of metalloproteinases (TIMP). TIMP-1,
TIMP-2, TIMP-3 and TIMP-4 genes have been isolat-
ed and their role in tumor and normal cell invasion
is being investigated2-4. The production of TIMP in a
small sample of cultured brain tumor explants and
cell lines has been examined in tumor tissues, nor-
mal brain, low passage number tumor-derived cell
lines and cultured normal astrocytes5. Another gene
that could function to inhibit tumor cell invasion is
the NM23-H1. This gene is expressed at higher levels
in tumor tissues derived from primary site melanomas
and breast carcinomas compared to distant metas-
tases6-8. Although a direct functional role for this gene
in the establishment of metastases has not yet been
experimentally determined, it appears that reduced
levels of gene product could aid metastatic spread.
It is unclear if the gene is involved in tumor cell inva-
sion or in seeding of invaded tumor at distant sites.
The cloned human NM23-H1 gene encodes nucleo-
side diphospate (NDP) kinase A9 and has a nucleic
acid sequence homology to NDP-kinase from Droso-
phila melanogaster. NDP kinase functions in the syn-
thesis of nucleotide triphosphates others than ATP. 
Since NM23-H1 could be involved in tumor cell in-
vasion inhibition, we have examined the levels of
NM23-H1 in diffuse astrocytomas and glioblastoma
multiforme (GMB).
METHOD
Tumor samples – 27 tumor tissues were removed from
patients undergoing neurosurgical procedures at the
Neurological Institute of Columbia University. A portion of
the tumor was sent for histopathological diagnosis by a
neuropathologist. Detailed reports of the tumor specimen
were the basis for tumor classification. Another portion
was snap-frozen in liquid nitrogen and stored at –70°C for
subsequent molecular characterization. A subset of tumors
was divided into a third portion and these tissues were
established as tumor-derived cell lines. Cells for culture
were dispersed in trypsin: EDTA and grown in plastic tissue
culture dishes in Dulbecco’s minimal essential medium con-
taining 20% fetal bovine serum. 
Extraction of RNA – Total celular RNA and DNA were
simultaneously extracted from frozen tissue samples using
guanidinium-isothiocyanate and cesium chloride gradients
Northern blot – Total RNA (10 µg per sample) from
tumor tissues were size-fractionated through 1% agarose-
formaldehyde gels and transferred to Amersham nylon fil-
ters. RNA immobilized on the filters was hybridized to 32P-
labeled DNA probes and placed next to X-ray film for au-
toradiography. Levels of specific RNAs were determined by
computer-assisted laser densitometry (Molecular Dynamics,
Inc.) of the autoradiographs. Blot filters were sequentially
hybridized to radiolabeled NM23-H1 and TIMP-1 probes in
addition to glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) probe to determine normal continually expressed
gene RNA levels. The GADPDH control RNA levels were
important to accurately compare the various samples to
one another since they can reflect differences in RNA load-
ing onto gels and spectrophotometric quantitation errors.
The GAPDH levels were compared to ethidium bromide-
stained total RNAs to insure the accuracy of using GAPDH
RNA level standardization among samples.
Statistical analysis was carried out according to t-test
for equality of means.
RESULTS
The bands from the autoradiographs are depict-
ed in Figures 1A-4A and graphs comparing relative
gene expression, based on computer-assisted laser
densitometry of the autoradiographic signals, are
presented in Figures 1B-4B. The relative levels of RNAs
were different depending on the probe used in the
blot hybridization. TIMP-1 RNA levels were more vari-
able from tumor to tumor compared to levels of
NM23-H1 RNA. GAPDH RNA levels were used to accu-
rately determine the physical amount of sample
loaded into each gel. Total RNAs were visualized after
gel electrophoresis and documented by photogra-
phy. The 28S and 18S ribosomal RNAs served as size
markers to determine the size of the mRNAs that
were detected as bands after Northern blot analysis.
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The ribosomal RNAs also served to document differ-
ences in the physical amounts of RNAs loaded per
sample. There were variations in the amounts of RNA
loaded per lane and these variations were in 100%
correspondence with the variations detected after
laser densitometry of bands generated using a
GAPDH probe. For each RNA sample, absorbance val-
ues of TIMP-1-specific bands or NM23-H1-specific
bands were divided by the absorbencies of GAPDH
bands to generate relative gene expression values. 
Figures 1A and B, 4A and B depict the bands
detected after Northern blot analyses of RNA extract-
ed from 27 primary tumor tissues removed at time
of surgery. Total cellular RNA was used in these analy-
ses. 
Figures 1A and B depicts RNAs from seven GBM
samples. 
Regarding to TIMP-1 gene expression: RNA sam-
ple (694) revealed a significant TIMP-1 increase rela-
tive to GAPDH. Lower levels were obtained in four
samples according to laser densitometry and RNA
sample (721) was significantly decreased relative to
GAPDH. 
Regarding to NM23-H1 gene expression: Higher
RNA level was detected in one sample (437) while
three samples (694, 721 and 727) were less than half
of the mean densitometry ratios.
Figures 2A and B depicts RNAs from three diffuse
astrocytomas (541,632,182) and four GBMs (555,657,
728,756). 
TIMP-1 RNA levels in diffuse astrocytomas were
extremely high compared to levels in all other sam-
ples analyzed in this blot. The GBMs samples either
severely down-regulated expression of TIMP-1 or they
shut off its expression completely. 
In contrast to TIMP-1, NM23-H1 RNA levels were
easily detected and there were no major differences
in the levels of expression in tumors from the astro-
cytic lineage.
Figures 3A and B contains eight GBM RNA samples.
Two tumors contained high levels of TIMP-1 RNA
(735,782). While six other tumors had low levels, less
than half of the mean densitometry ratios. 
NM23-H1 RNA levels in these samples were not
as variable. Only one sample (788) contained high le-
vel of NM23-H1 compared to the mean. The other
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Fig 1. Analysis of TIMP-1, NM23-H1 GAPDH RNA levels in GBM
tissue samples. Tumors were obtained at time of surgery. A)
Northern blot analysis: 10 µg of each RNA sample was size-frac-
tionated and analyzed. Ribosomal RNAs were visualized by
ethidium bromide staining to determine RNA quality and rel-
ative differences in the physical amount of RNA loaded per
lane. B) Quantitation of band signals: The amount of band sig-
nal on each autoradiograph was quantitated by computer-
assisted laser densitometry as described in Figure 1B.
Fig 2. Analysis of TIMP-1, NM23-H1 and  GAPDH RNA levels in
diffuse astrocytoma and GBM tissue samples. Tumors were
obtained at time of surgery. A) Northern blot analysis. B) Quan-
titation of band signals: diffuse astrocytoma (541,632,182) and
GBMs (555,657, 728,756).
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tumors did not appear too significantly up-regulate
or down-regulate NM23-H1 gene expression at RNA
levels.
Figures 4A and B depicts RNAs from five diffuse
astrocytomas.
There was variable TIMP-1 gene expression in this
set of tumors. Sample (64) contained significantly
higher amounts of TIMP-1 RNA compared to the oth-
er tumors in the series. Tumor sample (4,70) contained
an intermediate amount of this RNA. 
Statistical analyses were carried out according to
t-test for equality of means (Tables 1, 2, 3).
TIMP-1 and diffuse astrocytoma showed that the
mean ratio TIMP-1/GAPDH was in 2.17 and standard
deviation (SD) 1.99. The confidence interval with lev-
el of significance of 5% presented with values from
0.5 and 3.83. TIMP-1 and GBM the mean ratio TIMP1/
GAPDH was 0.45 and SD 0.67. The confidence inter-
val with level of significance of 5% presented limits
of 0.13 and 0.77. Analysis of equality of variances
(0.05 significance level was considered for all analy-
sis) found to TIMP-1 gene the rejection of hypothe-
sis of equality of variances, then it was used t test to
Fig 3. Analysis of TIMP-1 NM23-H1 and GAPDH RNA levels in
eight GBM tissue samples. Tumors were obtained at time of
surgery. A) Northern blot analysis. B) Quantitation of band 
signals.
Fig 4. Analysis of  TIMP-1 and GAPDH RNA levels in five diffuse
astrocytoma tissue samples. Tumors were obtained at time of
surgery. A) Northern blot analysis:  B) Quantitation of band
signals.
Table 1. Descriptive statistics (Laser densitometry ratios NM23-H1 and TIMP-1 RNA levels comparing with control gene RNA
levels in gliomas).
Number Mean SD Std. Error 95% confidence interval of mean Lower Upper
observations Lower limit Higher limit
NM23-H1 ASTRO 3 0.16 0.02 0.01 0.11 0.22 0.14 0.18
GBM 19 0.30 0.20 0.05 0.20 0.40 0.00 0.74
Total 22 0.28 0.19 0.04 0.19 0.37 0.00 0.74
TIMP-1 ASTRO 8 2.17 1.99 0.70 0.50 3.83 0.53 5.86
GBM 19 0.45 0.67 0.15 0.13 0.77 0.00 2.94
Total 27 0.96 1.42 0.27 0.40 1.52 0.00 5.86
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equality of means taking in account unequal vari-
ances. The results showed that the means of these
two groups were different (p<0.05).
Statistical analysis of NM23-H1 and diffuse astro-
cytoma showed that the mean ratio NM23-H1/GAPDH
was 0.16 and SD 0.02. The confidence interval with
level of significance of 5% presented limits of 0.11
and 0.22. NM23-H1 and GBM the mean ratio NM23-
H1/GAPDH was 0.30 and SD 0.20. The confidence
interval with level of significance of 5% presented
limits of 0.20 and 0.40. Analysis of homogeneity of
variances (level of confidence: 5%) found to NM23-
H1 was not rejected the hypothesis of equality of va-
riances, then it was used t test to equality of means
taking in account same variances. The results showed
that the means of two groups were the same (p>
0.05).
DISCUSSION
Invasion of normal brain tissue by a glial tumor
cell has been a goal of many studies10. TIMP-1 inter-
acts with metalloproteinases to inhibit its collage-
nase activity. The balance between collagenase and
collagenase inhibitor appears to determine whether
a tumor cell can invade adjacent tissue. Most tumors
and normal cells produce a number of collagenas-
es11. Our aim was to determine it there was a differ-
ential invasiveness into adjacent normal brain as part
of their malignant phenotype. Our initial approach
to the study of TIMP-1 correlated with protein levels
and anticollagenase activity in other tumor systems.
There was a clear difference in the amounts of TIMP-
1 RNA in histopathologically defined well-differen-
tiated astrocytomas compared to malignant astrocy-
tomas, we have quantitated the levels in 27 differ-
ent samples from different patients. In the malignant
astrocytomas, there was a significant trend toward
the down-regulation of TIMP-1 gene expression as
evidenced by the lower amounts of accumulated
TIMP-1 RNA. This expression trend correlated with
the invasive capacity of the tumor. Apodaca exam-
ined collagenases and TIMP protein excretes into cul-
ture medium of five malignant glioma cell lines and
from cultured fetal astrocytes1. In agreement with
Table 2. Levene ‘s test for equality of variances.
Levene Degrees of Degrees of Significance
statistic freedom 1 freedom 2
NM23 3.52 1 20 0.075
TIMP-1 22.16 1 25 0.000
Table 3. Statistical analysis t-test for equality of means NM23-H1 and TIMP-1 in gliomas.
Levene’s test for 
equality of variances t-test for equality of means
F Significance t Degrees of Significance Mean Std. error 95% confidence
freedom (2-tailedl) difference difference interval of the
difference
Lower Upper
NM23 Equal 3.52 0.08 –1.11 20.00 0.279 –0.13 0.12 –0.38 0.12
variances
assumed
Equal –2.77 19.68 0.012 –0.13 0.05 –0.23 –0.03
variances
not assumed
TIMP-1 Equal 22.16 0.00 3.41 25.00 0.002 1.72 0.50 0.68 2.76
variances
assumed
Equal 2.39 7.68 0.045 1.72 0.72 0.04 3.39
variances
not assumed
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our RNA data, they detected collagenase and TIMP-
1 activity in conditioned medium from all of these
cells. 
Halaka et al. examined conditioned medium from
eight glioma explants cultured up to seven days5.
They reported varying amounts of TIMP production
and a tendency for invasive tumors to release less
TIMP-1 into culture medium. Nakagawa et al. confir-
med the TIMP-1 involvement with gliomas and me-
ningiomas, they did protein experiments and their
results are similar as ours12. Nakano and his group
published a very elegant study showing their conclu-
sions about the relationship of metalloproteinases,
TIMP-1 and TIMP-2, and also the interaction with
PMA, TNFα, EGF, IL-1α, IL-6 and TGF β1. They did Nor-
thern blot analysis in glioma cells and chemoinvasion
assay13.
Invasion is a complex interaction between metal-
loproteinases and inhibitors, in addition with the
modulation of some growth factors and cytokines14.
TIMP-1 RNA and NM23-H1 RNA in diffuse astrocy-
tomas and GBM samples extracted from tissue cul-
ture are mostly the same, because it is not a good
model for something which is very active. Other me-
chanisms are clearly involved and there is likely to be
a continual balance between the metalloproteinas-
es and their inhibitors15.
There are individual tumors that contained sig-
nificantly higher amounts of TIMP-1 RNA. It is possi-
ble believe the existence of chemical mediators of
TIMP-1 overexpression. It is supported by the fact of
high levels of TIMP-1 RNA are influenced by exter-
nal stimuli, internal cell regulatory control or a com-
bination of both gene expression control mechanisms. 
Since TIMP-1 levels are lower in specific malignant
astrocytomas, this gene may be involved in regulat-
ing tumor cell invasion. It is possible that therapeu-
tic regimens could be devised to deliver TIMP-1 pro-
tein or increase TIMP-1 gene expression to destroy
the activity of the TIMP-1 target, collagenase, and
ameliorate tumor cell invasion. Increased expression
of TIMP-1 mediated by the addition of exogenous
DNA can decrease the metastatic potential of the
genetically engineered cell16,17. The efficacy of TIMP-
1 gene replacement therapy will be dependent on
useful gene expression vectors that can be easily
delivered to patients18.
The role of NM23-H1 in tumor cell invasion was
determined by Liotta19. This gene is overexpressed in
primary melanomas compared to their respective
metastases and decreased in human primary infiltrat-
ing ductal breast carcinomas that exhibit lymph node
involvement. RNA expression of this gene in glial
tumors has not been evaluated. The levels of NM23-
H1 in glial tumors samples were not as varied as those
of TIMP-1 RNA in our data. We did not detect a sig-
nificant trend toward low expression of NM23-H1 in
the invasive astrocytomas. However, NM23-H1 was
present in all glial tumor sample. Our results did not
show any variation in NM23-H1 gene expression from
diffuse astrocytomas and glioblastoma cells. Resear-
chers have suggested that the NM23-H1 is responsi-
ble by the internal control of the invasion in malig-
nant tumors19-23.
The data presented in this paper suggest that
TIMP-1 is a candidate inhibitor of brain tumor inva-
sion. We presented samples from GBM in which low
or undetectable amounts of TIMP-1 RNA suggest that
one of the known mechanisms to inhibit tumor cell
invasion is impaired in these tumors. Replacement of
this gene product may be of therapeutic value to pa-
tients with brain tumors, slowing or statically inhibit-
ing their disease24,25. 
NM23-H1 was present in the entire glioma sam-
ples, but it did not vary in diffuse astrocytomas and
glioblastomas.
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